Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 22/06/20041 min de leitura
Guidances for Industry on Medical Imaging Drug and Biological Products; Availability
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing the availability of three guidances for industry on "Developing Medical Imaging Drug and Biological Products." These guidances are intended to assist developers of medical imaging drug and biological products (medical imaging agents) in planning and coordinating their clinical investigations and preparing and submitting investigational new drug applications (INDs), new drug applications (NDAs), biologics license applications (BLAs), abbreviated new drug applications (ANDAs), and supplements to NDAs or BLAs.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →